Patent · US Active

Method for treating tumour, pharmaceutical composition and medicinal kit

US10251876B2 · kind B2 · utility

5Cited by
6References
15Claims
0Family size

Inventors

Key dates

Filing dateJun 5, 2015
Grant dateApr 9, 2019
Priority date
Expiry dateJun 5, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopro-pylamine used for combating a tumor. Specially, the present invention refers to method for treating tumor, pharmaceutical composition and medicinal kit related to the described compound. Administrating the compound with a suitable dosage regimen can not only make the patient's plasma concentration maintain the level of 100 ng/ml or lower, but also achieve effects of treatments and obtain benefits for various tumours.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.